Your browser doesn't support javascript.
Trial Decline
Pharmaceutical Technology Europe ; 34(11):6, 2022.
Article in English | ProQuest Central | ID: covidwho-20243769
ABSTRACT
According to the Association of the British Pharmaceutical Industry (ABPI) there has been a significant decline in the number of industry clinical trials nitiated in the UK. "The COVID-19 pandemic has accelerated the decline in ate-stage industry clinical research in the UK, compared to its global peers," said Richard Torbett, chief executive of the ABPI in a press release (3). Findings from an ABPI report into the state of clinical trials in the UK has shown that consistently slow and variable set up times for clinical trials encountered in the NHS are causing some pharmaceutical companies to look elsewhere for clinical research (4). [...]a close relationship is needed between government and the life sciences sector now more than ever to ensure the country does not fall too far behind its global competitors.
Keywords
Search on Google
Collection: Databases of international organizations Database: ProQuest Central Type of study: Prognostic study / Randomized controlled trials Language: English Journal: Pharmaceutical Technology Europe Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: ProQuest Central Type of study: Prognostic study / Randomized controlled trials Language: English Journal: Pharmaceutical Technology Europe Year: 2022 Document Type: Article